In this study, the group for South Korea assess the institutional effect of repeat TURBT efficacy. They retrospectively reviewed the charts of 289 patients who undertwent repeat TURBT within 6 weeks of initial diagnosis, but stratified patients based on the institution where their repeat TURBT was completed. The mean follow-up was 50 months.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Based on this, they indicate that there is clearly a difference between the quality of initial TURBT done at outside institutions vs. referral centers. However, there is an inherent bias in this study – as only difficult cases were likely referred to their center. This is never accounted for. While there may be some basis to this statement, this abstract does not prove it.
Presented by: Min Young Yoon
Written by: Thenappan Chandrasekar, MD, Clinical Fellow, University of Toronto, twitter: @tchandra_uromd, at the 37th Congress of Société Internationale d’Urologie - October 19-22, 2017- Lisbon, Portugal